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Chlamydia pneumoniae  has been recognized as a common cause of community-acquired 
pneumonia (CAP) and other acute respiratory tract infections (ARIs) in various age groups.1 
Lately, the prevalence of Chlamydia-associated ARIs decreased to less than 1.5% 2, as a result of 
(i) changes in epidemiology of C. pneumoniae and (ii) increased specificity of new diagnostic 
molecular methods. Moreover, C. pneumoniae infection may remain undetected since clinicians 
may not screen the infected population. Indeed, Chlamydia pneumoniae has been recently 
identified as an agent of asthma exacerbation and has been associated with its severity, 3,4,5 thus 
reinforcing the importance to target these patients. In Lausanne, using a duplex real-time PCR, 
that detects C. pneumoniae and M. pneumoniae DNA6, we reported a 0.13% prevalence of C. 
pneumoniae positive PCRs (2/1583) and identified one patient with C. pneumoniae-associated 
asthma, who recovered with antibiotics7. Below, we report a case series of C. pneumoniae 
respiratory infections in children. 
From 10th September to 5th December 2013, 8 children were detected positive for C. pneumoniae 
from upper respiratory tract specimens (Table). Of these, 5 were admitted for either acute asthma 
exacerbation or asthmatic bronchitis. All but two patients presented with chronic cough without 
fever nor systemic symptoms. These two patients presented a co-infection with either rhinovirus 
or M. pneumoniae and were admitted for severe respiratory distress in the intensive care unit, 
intubated and mechanically-ventilated, respectively for a community-acquired pneumonia 
(patient 7) and for a severe asthma exacerbation (patient 8). Both patients with severe clinical 
presentation were known for pre-existing asthma condition. All patients were successfully 
treated with a macrolide. Interestingly, C. pneumoniae infection was detected by chance in 7 
patients as a result of the dual format of our PCR, because a Mycoplasma pneumoniae PCR was 
requested.   
In conclusion, this report supports the role of C. pneumoniae in asthma exacerbation. Whether C. 
pneumoniae-associated asthma may be cured with antibiotics or will also require steroids 
remains yet unknown and may vary from patient to patient. This case series underlines the 
importance of screening asthmatic children for C. pneumoniae. Moreover, our findings suggest 
that C. pneumoniae prevalence is likely underestimated and children with chronic cough, even in 
absence of fever, should be tested for C. pneumoniae.  
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Table. 
N Age 
years 
Gender° Asthmatic 
condition 
Cough 
duration 
Fever ICU° Sample 
 
Copies/ml Co-infection 
(copies/ml) 
Treatment Treatment 
duration 
1* 7 F asthma chronic yes no throat 1'743’796 no clarithromycin 14 days 
2 7 M asthma chronic yes no nasal 197’000 no clarithromycin 10 days 
3* 7 M None chronic no no throat 3100 no clarithromycin 10 days 
4 6 M None chronic no no nasal 60 no azithromycin 5 days 
5* 8 M asthmatic 
bronchitis 
chronic no no NP° 78’000 no clarithromycin 7 days 
6* 12 F None chronic no no NP° 61’000 no clarithromycin 7 days 
7 7 F asthma acute yes yes NP° 170 Mycoplasma 
pneumoniae 
(570) 
clarithromycin 14 days 
8 10 M asthma acute yes yes NP° 208 rhinovirus 
(13'071'000) 
erythromycin 14 days 
 
*patient originated from the same eastern region of VAUD canton (nearby Yverdon);   
°F: female, M: male; °NP : nasopharyngeal sample 
°ICU: admission to the intensive care unit (patient 7, for a community-acquired pneumonia; patient 8, for a severe 
asthma exacerbation)  
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